Financials
- Market Capitalization 217.49 M
- Employee 95
- Founded N/A
- CEO Daniel Vitt
- Website www.imux.com
- Headquarter Delaware, United States
- FIGI BBG001M75SX4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-0.86
ratio cours/chiffre d'affaires
-167.18
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3554 | CHRS Coherus Oncology, Inc. - Common Stock | 1.45 USD | -0.68% | +3.57% | +0.69% | -9.94% | 224.03 M USD | ||
| 3564 | KROS Keros Therapeutics, Inc. - common stock | 11.23 USD | +0.99% | +3.31% | +10.75% | -25.63% | 222.66 M USD | ||
| 3572 | ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 3.01 USD | -0.66% | -6.81% | +31.44% | +122.96% | 217.68 M USD | ||
| 3573 | BCYC Bicycle Therapeutics plc - American Depositary Shares | 4.33 USD | -0.69% | -1.37% | +10.18% | -39.36% | 218.90 M USD |